PHOENIX NEW MED.ADR 1/48 (F:1PX) — Stock Price
PHOENIX NEW MED.ADR 1/48 (F:1PX) is currently trading at €1.44 EUR, down 0.69% today. Over the past 52 weeks, shares have ranged between €1.43 and €2.62. This page tracks PHOENIX NEW MED.ADR 1/48's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see PHOENIX NEW MED.ADR 1/48 (1PX) cash flow conversion.
PHOENIX NEW MED.ADR 1/48 (1PX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PHOENIX NEW MED.ADR 1/48's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
PHOENIX NEW MED.ADR 1/48 Income Statement — Revenue, Profit & Earnings by Year
PHOENIX NEW MED.ADR 1/48's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €765.57 Million | €703.70 Million | €692.02 Million | €785.71 Million | €1.03 Billion |
| Cost of Revenue | €391.42 Million | €434.99 Million | €464.14 Million | €548.50 Million | €597.40 Million |
| Gross Profit | €374.15 Million | €268.71 Million | €227.88 Million | €237.20 Million | €432.93 Million |
| Research & Development | €64.60 Million | €70.75 Million | €82.66 Million | €131.81 Million | €158.59 Million |
| SG&A | €343.93 Million | €262.68 Million | €270.91 Million | €296.83 Million | €610.44 Million |
| Total Operating Expenses | €799.95 Million | €768.42 Million | €817.72 Million | €977.14 Million | €1.37 Billion |
| Operating Income | €-34.38 Million | €-64.72 Million | €-125.70 Million | €-191.44 Million | €-336.10 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Before Tax | €8.52 Million | €-48.30 Million | €-96.14 Million | €-196.11 Million | €-252.49 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €336.00K | €-53.55 Million | €-102.50 Million | €-109.65 Million | €-205.70 Million |
PHOENIX NEW MED.ADR 1/48 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PHOENIX NEW MED.ADR 1/48's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €1.65 Billion | €1.71 Billion | €1.76 Billion | €2.03 Billion | €2.41 Billion |
| Total Current Assets | €1.42 Billion | €1.47 Billion | €1.48 Billion | €1.66 Billion | €2.08 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €464.23 Million | €428.34 Million | €558.76 Million | €1.05 Billion | €1.31 Billion |
| Net Receivables | €274.30 Million | €296.78 Million | €270.43 Million | €428.40 Million | €438.71 Million |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €541.47 Million | €598.52 Million | €595.12 Million | €765.60 Million | €1.02 Billion |
| Total Current Liabilities | €498.25 Million | €537.32 Million | €526.99 Million | €664.32 Million | €966.98 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €1.17 Billion | €1.18 Billion | €1.23 Billion | €1.32 Billion | €1.43 Billion |
| Retained Earnings | €-567.46 Million | €-566.70 Million | €-513.37 Million | €-411.07 Million | €-300.36 Million |
PHOENIX NEW MED.ADR 1/48 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PHOENIX NEW MED.ADR 1/48 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-2.67 Million | €-44.30 Million | €-60.83 Million | €-312.41 Million | €-142.82 Million |
| Capital Expenditures | €13.04 Million | €5.22 Million | €9.72 Million | €33.96 Million | €16.83 Million |
| Free Cash Flow | €-15.71 Million | €-49.52 Million | €-70.54 Million | €-346.37 Million | €-159.66 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | €-1.00 Million | €-1.90 Million | €-655.00K | €0.00 | €-3.54 Million |
| Dividends Paid | — | — | €0.00 | €0.00 | €3.54 Million |
| Stock-Based Compensation | €17.00K | €1.54 Million | €3.71 Million | €7.88 Million | €9.58 Million |
| Depreciation | €27.12 Million | €34.92 Million | €42.56 Million | €54.75 Million | €66.05 Million |
| Change in Cash | €-63.69 Million | €82.88 Million | €429.42 Million | €-99.56 Million | €-184.24 Million |
PHOENIX NEW MED.ADR 1/48 Earnings History — EPS Actual vs. Analyst Estimates
Track PHOENIX NEW MED.ADR 1/48's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 12, 2026 | — | — | — |
| Mar 10, 2026 | — | — | — |
| Nov 12, 2025 | — | — | — |
| Aug 12, 2025 | — | — | — |
| May 12, 2025 | — | — | — |
| Mar 10, 2025 | — | — | — |
| Nov 12, 2024 | — | — | — |
| Aug 15, 2023 | -0.34 | — | — |